Related Experiment Video
Updated: Oct 17, 2025

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Pyroptosis in Kidney Disease
Yujia Wang1, Yinshuang Li1, Yanfang Xu1
1Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
Abstract:
In the last several decades, apoptosis interference has been considered clinically irrelevant in the context of renal injury. Recent discovery of programmed necrotic cell death, including necroptosis, ferroptosis, and pyroptosis refreshed our understanding of the role of cell death in kidney disease. Pyroptosis is characterized by a lytic pro- inflammatory type of cell death resulting from gasdermin-induced membrane permeabilization via activation of inflammatory caspases and inflammasomes. The danger-associated molecular patterns (DAMPs), alarmins and pro-inflammatory cytokines are released from pyroptotic cells in an uncontrolled manner, which provoke inflammation, resulting in secondary organ or tissue injuries. The caspases and inflammasome activation-related proteins and pore-forming effector proteins known as GSDMD and GSDME have been implicated in a variety of acute and chronic microbial and non-microbial kidney diseases. Here, we review the recent advances in pathological mechanisms of pyroptosis in kidney disease and highlight the potential therapeutic strategies in future.
Insights
Programmed cell death, including pyroptosis, plays a key role in kidney disease. Understanding pyroptosis mechanisms and GSDMD/GSDME proteins offers new therapeutic strategies for renal injury.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Apoptosis interference was previously deemed irrelevant in renal injury.
- Recent discoveries in programmed necrotic cell death (necroptosis, ferroptosis, pyroptosis) have reshaped understanding of cell death in kidney disease.
- Pyroptosis, a lytic, pro-inflammatory cell death, involves inflammasomes and caspases, leading to DAMPs release and secondary injury.
Purpose of the Study:
- To review recent advances in the pathological mechanisms of pyroptosis in kidney disease.
- To highlight potential future therapeutic strategies targeting pyroptosis.
Main Methods:
- Review of current literature on pyroptosis in kidney disease.
- Analysis of the roles of caspases, inflammasomes, GSDMD, and GSDME in renal pathology.
Main Results:
- Pyroptosis is implicated in various acute and chronic kidney diseases.
- Gasdermin proteins (GSDMD, GSDME) are key effectors in pyroptosis.
- Uncontrolled release of DAMPs and cytokines from pyroptotic cells drives inflammation and tissue damage.
Conclusions:
- Pyroptosis is a significant contributor to kidney disease pathogenesis.
- Targeting pyroptosis pathways presents promising therapeutic avenues for renal injury.
Related Concept Videos
Nephrons
Acute Kidney Injury II: Pathophysiology
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis I: Introduction
Acute Kidney Injury I: Introduction

